The 2013 impact factor of the "Pol Arch Med Wewn" by Undas, Anetta
EDITORIAL The 2013 impact factor of the Pol Arch Med Wewn 1
could be published in the Pol Arch Med Wewn or 
even a better journal as long as the authors do 
not give up on their publication efforts.
Given that the English language has become 
the lingua franca of international scientific com-
munication, the publication of good-quality re-
search in the Pol Arch Med Wewn may be ham-
pered for linguistic reasons. We are obliged not 
to publish novel observations if they are not com-
municated in proper English, even if we have not 
been very strict on this issue so far. I am aware 
of the fact that, sometimes, we accept less inno-
vative but well-written articles submitted by au-
thors who are fluent in English or who had their 
articles proofread by professionals.
Apart from publishing regular review and re-
search articles, the journal also features Clinical 
Images and Letters to the Editor reporting re-
cent exciting findings or interesting preliminary 
data. Both these sections have been quite popu-
lar, and, in our opinion, they will contribute to 
our future impact factor. Therefore, we strongly 
encourage you to submit clinical images and let-
ters to the Pol Arch Med Wewn.
We are proud to have published 3 original pa-
pers in the present issue written by students in-
terested in internal medicine and research.7-9 We 
hope that the publication in a journal with an im-
pact factor above 2 will be the first step in the sci-
entific career of those young Polish investigators.
Is it time now to change the official title of our 
journal into English—Polish Archives of Internal 
Medicine—to make it more international? The 
change of the title, with its predicted positive 
effect on the quality and impact of submissions, 
could help promote Polish clinical science. How-
ever, such a decision will need to be approved by 
the authorities of the Polish Society of Internal 
Medicine. The decision will be made within the 
next few months.
I look forward to the continued support of 
Polish researchers and clinicians in the years to 
come, so that together we can enhance the quali-
ty of science we publish in the Pol Arch Med Wewn 
with a further increase in impact factor in 2014 
and beyond.
Dear Readers, Dear Colleagues!
Good news for our journal, the Pol Arch Med 
Wewn, a monthly peer-reviewed journal on in-
ternal medicine and published on behalf of the 
Polish Society of Internal Medicine in partner-
ship with the publisher, Medycyna Praktyczna.
I am delighted to inform you that the lat-
est impact factor of our journal—for the year 
2013—is 2.052. I would like to thank you all—
our authors, reviewers, and editorial board mem-
bers—for your invaluable contribution to the 
journal’s success. The most cited article published 
in our journal in 2011 was a review article writ-
ten by a group of Polish scientists, Staszel et al.,1 
followed by an original article by Polakowska and 
Piotrowski,2 and a review article by Undas.3 In 
2012, again, the most cited article was a review 
(written by Lipinski and Pretorius),4 followed 
by original research papers by Ulasli et al.5 and 
Kwaśny-Krochin et al.6
Looking at a higher impact factor (1.833 for 
the year 2012) and in view of the recent editori-
al work, I have some comments to share with our 
readers and future authors. Owing to a growing 
number of articles being submitted for publica-
tion in the Pol Arch Med Wewn, we are able to pub-
lish only a minority of the submitted papers (less 
than 25%). Only the best papers in the opinion 
of Editors, supported by the members of the Na-
tional Editorial Board, are sent for review without 
guarantee for publication. Since we now reject a 
substantial number of good papers on the basis 
of a preliminary evaluation by journal editors and 
without peer-review, such a decision can be quite 
disappointing to authors and I do receive letters 
from authors expressing their concern. I hope 
that our decisions are for the sake of our journal; 
however, I advise all authors to state explicitly in 
the cover letter why they feel their paper should 
be published in our journal (for example, unique 
study population, novel methodology, new diag-
nostic or treatment strategies, etc.) In addition, 
the novelty of their research should be empha-
sized and discussed in the Discussion section of 
their papers. I believe that every interesting piece 
of research supported by sound methodology 
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